Purpose Recent years have seen remarkable progress in cancer therapy, although
treatment-induced adverse reactions and complications are not uncommon. Approximately …

Background: Surprisingly little is known about the burden of oral mucositis (OM). We provide
a systematic review of studies on the burden of OM (incidence, economic impact, health …

Background The ability to consistently and accurately assess oral mucositis (OM) is critical to
descriptions of its incidence and severity and in evaluating the effectiveness of potential …

BACKGROUND Oral and gastrointestinal (GI) mucositis can affect up to 100% of patients
undergoing high‐dose chemotherapy and hematopoietic stem cell transplantation, 80% of …

Oral Mucositis (OM) is among the most common and dreaded toxicities of cancer therapy. It
occurs in almost all patients who receive radiation therapy in which areas of oral and …

Background Oral mucositis is a side effect of chemotherapy, head and neck radiotherapy,
and targeted therapy, affecting over 75% of high‐risk patients. Ulceration can lead to severe …

Purpose To update the clinical practice guidelines for the use of growth factors and
cytokines for the prevention and/or treatment of oral mucositis (OM). Methods A systematic …

Abstract Purpose/Objectives: To review novel approaches to assessing and managing
patients with cancer who are at risk for oral mucositis. Data Sources: Published research …

Background Oral mucositis is a debilitating consequence of radiotherapy in patients with
head and neck cancers. Radiation-induced oral mucositis (RIOM) can cause pain and …

Mucositis is a common and feared complication of anticancer therapy that can affect up to
90% of certain populations of patients with cancer. Even seemingly uncomplicated …